Search
01/01/2022
Leishmaniasis and anti-TNF drugs
Sánchez-Rodríguez G., Puig L.. Leishmaniasis and anti-TNF drugs. Piel. 2022; 37(6)DOI:10.1016/j.piel.2021.06.020. PMID:. IF:(Q/D).
01/01/2022
International eDelphi Study to Reach Consensus on the Methotrexate Dosing Regimen in Patients With Psoriasis
Van Huizen A.M., Menting S.P., Gyulai R., Iversen L., Van Der Kraaij G.E., Middelkamp-Hup M.A., Warren R.B., Spuls P.I., Schejtman A.A., Egeberg A., Firooz A., Kumar A.S., Oakley A., Foulkes A., Ramos A.M.C., Fougerousse A.-C., Carija A., Akman-Karakas A., Horváth B., Fábos B., Matlock B.H., Claréus B.W., Castro C., Ferrándiz C., Correa C.C., Marchesi C., Goujon C., Gonzalez C., Maldonado-García C., Hong C.-H., Griffiths C.E.M., Vestergaard C., Echeverría C.M., De La Cruz C., Conrad C., Törocsik D., Drvar D.L., Balak D., Jullien D., Appelen D., Kim D.H., De Jong E.M.G.J., El Gamal E., Laffitte E., Mahé E., Sonkoly E., Colombo E.P., Vilarrasa E., Willaert F., Novoa F.D., Handjani F., Valenzuela F., Vílchez-Márquez F., Gonzalez G.O., Krisztián G., Damiani G., Krnjevic-Pezic G., Pellerano G., Carretero G., Hunter H.J.A., Riad H., Oon H.H., Boonen H.P.J., Moussa I.O., García-Doval I., Csányi I., Brajac I., Turchin I., Grozdev I., Weinberg J.M., Nicolopoulos J., Wells J., Lambert J.L.W., Ingram J.R., Prinz J.C., De Souza Sittart J.A., Sanchez J.L., Hsiao J.P.-F., Castro-Ayarza J.R., Maul J.-T., Van Den Reek J.M.P.A., Trcko K., Barber K., Reich K., Gebauer K.A., Khobzei K., Maul L.V., Massari L.P., Fardet L., Le Cleach L., Misery L., Chandrashekar L., Muresanu L.I., Lecluse L., Skov L., Frez M.L., Babic L.T., Puig L., Gomez L.C., Ramam M., Dutil M., El-Sayed M.H., Olszewska M., Schram M.E., Franco M.D., Llamas-Velasco M., Gonçalo M., Velásquez-Lopera M.M., Abad M.E., De Oliveira M.D.F.S.P., Seyger M.M.B., Kaštelan M., Rademaker M., Sikora M., Lebwohl M., Wiseman M.C., Ferran M., Van Doorn M., Danespazhooh M., Bylaite-Bucinskiene M., Gooderham M.J., Polic M.V., De Rie M.A., Zheng M., Gómez-Flores M., Salleras I Redonnet M., Silverberg N.B., Doss N., Yawalkar N., Chosidow O., Zargari O., De La Cueva P., Fernandez-Peñas P., Cárdenas Rojas P.J., Gisondi P., Grewal P., Sator P., Luna P.C., Félix P.A.O., Varela P., Holló P., Cetkovska P., Calzavara-Pinton P., Ghislain P.-D., Araujo R.R., Romiti R., Kui R., Ceovic R., Vender R., Lafuente-Urrez R.F., Del-Río R., Gulin S.J., Handa S., Mahil S.K., Kolalapudi S.A., Marrón S.E., Azimi S.Z., Janmohamed S.R., Da Cruz Costa S.A., Choon S.E., Urbancek S., Ayanlowo O., Margasin S.M., Wong T.-W., Mälkönen T., Hurtová T., Reciné T.R., Huldt-Nystrøm T., Torres T., Liu T.-Y., Leonidze T., Sharma V.K., Weightman W., Gulliver W., Veldkamp W.. International eDelphi Study to Reach Consensus on the Methotrexate Dosing Regimen in Patients With Psoriasis. JAMA Dermatology. 2022; 158(5)DOI:10.1001/jamadermatol.2022.0434. PMID:35353175. IF:10.900(Q1/1D).
01/01/2022
Matching-adjusted indirect comparison of efficacy outcomes in trials of calcipotriol plus betamethasone dipropionate foam and cream formulations for the treatment of plaque psoriasis
Papp K.A., Thoning H., Gerdes S., Megna M., Brandi H., Jablonski Bernasconi M.Y., Yélamos O.. Matching-adjusted indirect comparison of efficacy outcomes in trials of calcipotriol plus betamethasone dipropionate foam and cream formulations for the treatment of plaque psoriasis. JOURNAL OF DERMATOLOGICAL TREATMENT. 2022; 33(7)DOI:10.1080/09546634.2022.2095330. PMID:35875991. IF:2.900(Q2/4D).
01/01/2022
Effect of a Perioperative Hypotension-Avoidance Strategy Versus a Hypertension-Avoidance Strategy on the Risk of Acute Kidney Injury: A Clinical Research Protocol for a Substudy of the POISE-3 Randomized Clinical Trial
Garg, AX, Cuerden, M, Aguado, H, Amir, M, Belley-Cote, EP, Bhatt, K, Biccard, BM, Borges, FK, Chan, M, Conen, D, Duceppe, E, Efremov, S, Eikelboom, J, Fleischmann, E, Giovanni, L, Gross, P, Jayaram, R, Kirov, M, Kleinlugtenbelt, Y, Kurz, A, Lamy, A, Leslie, K, Likhvantsev, V, Lomivorotov, V, Marcucci, M, Martinez-Zapata, MJ, McGillion, M, McIntyre, W, Meyhoff, C, Ofori, S, Painter, T, Paniagua, P, Parikh, C, Parlow, J, Patel, A, Polanczyk, C, Richards, T, Roshanov, P, Schmartz, D, Sessler, D, Short, T, Sontrop, JM, Spence, J, Srinathan, S, Stillo, D, Szczeklik, W, Tandon, V, Torres, D, Van Helder, T, Vincent, J, Wang, CY, Wang, M, Whitlock, R, Wittmann, M, Xavier, D, Devereaux, PJ. Effect of a Perioperative Hypotension-Avoidance Strategy Versus a Hypertension-Avoidance Strategy on the Risk of Acute Kidney Injury: A Clinical Research Protocol for a Substudy of the POISE-3 Randomized Clinical Trial. Canadian Journal Of Kidney Health And Disease. 2022; 9DOI:10.1177/20543581211069225. PMID:35024154. IF:(Q/D).